NCT04205864

Application of Thrombin Gel Matrix for the Prevention of Lymphocele in Patients With Endometrial Cancer.

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 72 (actual)
• Sponsor: Kocaeli University · Academic / Other
• Sex: Female
• Age: 18 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

To compare the incidence of lymphocele in Endometrial cancer patients with thrombin gel matrix used and not used during pelvic lymph node dissection.

Detailed description

Pelvic lymph node dissection is the most accurate staging tool to determine lymph node involvement in endometrial cancer. Lymphoceles developed after surgery can cause serious morbidity, additional costs and delays in chemotherapy or radiotherapy. In this study, conventional pelvic lymphadenectomy will be compared with thrombin gel matrix application after pelvic lymphadenectomy. Our goal is to prospectively assess the lymphostatic effect of thrombin gel matrix in endometrial cancer patients undergoing pelvic lymph node dissection.

Conditions

• Lymphocele
• Lymphocele After Surgical Procedure
• Endometrium Cancer

Interventions

Type	Name	Description
DRUG	Thrombi-Gel	Thrombin gel Matrix applied on pelvic lymphadenectomy areas after lympadenectomy
PROCEDURE	Conventional Pelvic lymphadenectomy	Conventional Pelvic lymphadenectomy

Timeline

• Start date: 2019-12-20
• Primary completion: 2020-07-01
• Completion: 2020-07-02
• First posted: 2019-12-20
• Last updated: 2020-07-07

Locations

1 site across 1 country: Turkey (Türkiye)